Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Dallas › NPI 1528027786
Clinic

Methodist Hospitals of Dallas

Methodist Hospitals of Dallas was paid $12.59M by Medicaid between Jul 2019 and Dec 2024, across 203 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.

33Billing provider infoMETHODIST HOSPITALS OF DALLAS
DALLAS, TX 75203
33aNPI1528027786assigned 03/17/2006
28Total paid$12.59M
24GClaims403,245
24DCodes billed203
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers

Next to other Ambulatory Surgical Clinic/Center providers in Texas

Rank by total paid#39 of 320
Median peer was paid$205K
This provider vs. median61×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019294$4K
202024,530$511K
2021100,420$2.51M
2022105,350$3.55M
2023111,722$3.92M
2024incomplete60,929$2.10M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 13,639 12,540 $2.94M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 25,281 23,420 $1.87M
G0378 Hospital observation service, per hour 6.4% 3,987 2,410 $806K
80053 Comprehensive metabolic panel 4.7% 26,767 21,514 $594K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4.6% 12,060 10,239 $579K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.7% 1,773 1,651 $469K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.5% 3,785 3,229 $439K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.4% 38,332 27,875 $423K
70450 Computed tomography, head or brain; without contrast material 2.1% 2,856 2,591 $270K
71045 Radiologic examination, chest; single view 2.0% 10,360 9,026 $257K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1.7% 3,704 3,293 $218K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.6% 3,185 2,283 $206K
191 more codes
74176 Computed tomography, abdomen and pelvis; without contrast material 1.4% 1,109 $178K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.3% 5,562 $165K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 2,652 $153K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.2% 3,125 $148K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.1% 3,781 $141K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.1% 375 $140K
84703 <1% 11,674 $117K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,820 $107K
83880 <1% 3,368 $105K
81001 <1% 13,306 $99K
84484 <1% 9,406 $97K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 223 $94K
96361 Intravenous infusion, hydration; each additional hour <1% 4,021 $93K
72125 Computed tomography, cervical spine; without contrast material <1% 1,039 $91K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,309 $83K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 3,484 $82K
84702 <1% 4,093 $80K
83690 <1% 8,460 $74K
76801 <1% 693 $70K
99214 Doctor's office visit, returning patient (more involved) <1% 606 $67K
71046 Radiologic examination, chest; 2 views <1% 1,795 $61K
80050 General health panel <1% 360 $46K
84145 <1% 2,093 $41K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 178 $40K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 949 $37K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 946 $37K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,029 $35K
80048 Basic metabolic panel (calcium, ionized) <1% 4,871 $34K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 420 $34K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 826 $34K
83605 <1% 3,437 $33K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 180 $33K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 729 $30K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,515 $28K
86850 <1% 1,693 $28K
80320 <1% 1,904 $27K
71275 Computed tomographic angiography, chest, with contrast material <1% 108 $27K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 737 $27K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 233 $25K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 222 $25K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,559 $24K
87040 <1% 3,021 $23K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,989 $22K
83735 <1% 5,451 $22K
80069 <1% 4,360 $21K
80143 <1% 979 $21K
93976 <1% 237 $20K
80179 <1% 889 $18K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 319 $18K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,208 $17K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,945 $16K
82550 <1% 3,001 $16K
73030 <1% 522 $15K
85730 <1% 3,226 $14K
81003 <1% 3,817 $14K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,887 $14K
85610 <1% 4,590 $14K
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 112 $13K
73564 <1% 311 $12K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 1,054 $12K
93971 <1% 111 $12K
96375 Therapeutic injection; each additional sequential IV push <1% 6,422 $11K
73610 <1% 314 $11K
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,905 $11K
90715 <1% 535 $11K
86769 <1% 329 $10K
72100 <1% 250 $10K
77067 Screening mammography, bilateral, including computer-aided detection <1% 152 $9K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 81 $8K
82803 <1% 513 $8K
85379 <1% 953 $8K
73630 <1% 227 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 896 $7K
87186 <1% 1,023 $7K
97162 <1% 81 $7K
86900 <1% 2,596 $6K
86901 <1% 2,587 $6K
73590 <1% 252 $6K
84100 <1% 2,390 $6K
77063 Screening digital breast tomosynthesis, bilateral <1% 152 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,759 $5K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 105 $5K
80061 Lipid panel <1% 563 $5K
80047 <1% 582 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,393 $4K
71250 <1% 40 $4K
73562 <1% 103 $4K
82728 <1% 471 $4K
76830 Ultrasound, transvaginal <1% 37 $4K
72131 <1% 38 $4K
73502 <1% 127 $4K
87210 <1% 619 $4K
87340 <1% 703 $4K
87081 <1% 516 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,445 $4K
86140 <1% 990 $4K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 53 $4K
83721 <1% 544 $3K
73130 <1% 78 $3K
73552 <1% 125 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 118 $3K
94060 <1% 31 $3K
99204 Doctor's office visit, new patient (more involved) <1% 29 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 2,083 $2K
72170 <1% 85 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,842 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 15 $2K
94644 <1% 40 $2K
80076 <1% 263 $2K
87077 <1% 357 $2K
90686 <1% 119 $2K
85018 <1% 765 $2K
82553 <1% 167 $2K
70486 <1% 13 $2K
85014 <1% 1,081 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,444 $1K
94726 <1% 14 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,690 $1K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 57 $1K
97116 <1% 48 $1K
83615 <1% 265 $1K
87088 <1% 195 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 227 $1K
J1940 Injection, furosemide, up to 20 mg <1% 608 $1K
J1790 Injection, droperidol, up to 5 mg <1% 285 $1K
82570 <1% 715 $1K
87807 <1% 31 $1K
94664 <1% 2,181 $977.64
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,475 $972.72
94729 <1% 16 $952.02
96367 <1% 28 $888.23
82800 <1% 228 $855.74
J0690 Injection, cefazolin sodium, 500 mg <1% 633 $806.79
73110 <1% 13 $737.73
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,452 $635.24
73560 <1% 20 $590.49
80197 <1% 473 $575.31
72040 <1% 12 $530.48
84156 <1% 458 $513.65
J3490 Unclassified drugs <1% 1,916 $512.29
J1953 Injection, levetiracetam, 10 mg <1% 21 $510.02
86703 <1% 18 $482.95
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 9,153 $470.09
84443 Thyroid stimulating hormone (TSH) <1% 44 $464.87
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 12 $460.02
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 556 $429.88
82565 <1% 136 $379.10
90685 <1% 51 $360.18
82947 <1% 241 $342.01
87070 <1% 51 $324.75
J3370 Injection, vancomycin hcl, 500 mg <1% 17 $287.33
85651 <1% 79 $277.14
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 15 $274.18
J3475 Injection, magnesium sulfate, per 500 mg <1% 58 $273.77
J2060 Injection, lorazepam, 2 mg <1% 518 $268.04
80051 <1% 45 $253.73
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 144 $230.75
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 55 $211.95
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 821 $209.35
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,018 $208.18
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 532 $206.40
82962 <1% 14,690 $191.65
87205 <1% 53 $181.25
87075 <1% 31 $178.59
82150 <1% 30 $172.71
86592 <1% 16 $163.86
82607 <1% 17 $159.46
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 15 $138.57
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 15 $131.70
84520 <1% 46 $128.67
J2550 Injection, promethazine hcl, up to 50 mg <1% 156 $65.73
C1769 Guide wire <1% 358 $63.82
83550 <1% 16 $51.00
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 31 $46.16
83540 <1% 15 $37.72
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 104 $36.65
82374 <1% 50 $29.41
84132 <1% 65 $22.43
J1171 Injection, hydromorphone, 0.1 mg <1% 26 $22.21
J2704 Injection, propofol, 10 mg <1% 994 $20.67
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 31 $19.32
36415 Collection of venous blood by venipuncture <1% 1,450 $18.13
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 369 $14.00
84295 <1% 37 $7.38
96376 0% 845 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 29 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 0% 15 $0.00
88738 0% 15 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 24 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 13 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBJERKE, CRAIG (EXECUTIVE VP & CFO)
Same official

Other billing entities under BJERKE, CRAIG

Full network →
ProviderLocationPaid
Methodist Hospitals of DallasDallas, TX$13.18M
Methodist Hospitals of DallasMansfield, TX$3.20M
Methodist Hospitals of DallasRichardson, TX$2.65M
Methodist Hospitals of DallasMidlothian, TX$2.35M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.